Garofalo et al. [48] showed that miR-221, by targeting PTEN and TIMP3 tumor suppressors, induced TRAIL resistance and enhance cellular migration through the activation of the AKT pathway and metallopeptidases. This evidence concerns the gene PTEN and neoplasm.